A First-in-Human Safety Trial of MTX-474

NCT06535841 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mediar Therapeutics